Acquiring convalescent specimens to isolate and identify potent monoclonal antibodies against COVID-19
Study of People Who Have Recovered from COVID-19 to Isolate Monoclonal Antibodies Against COVID-19
Sponsor: Columbia University
Enrolling: Male and Female Patients
Clinic Visits: 1
IRB Number: AAAS9517
Contact: Brett Gray: 000-000-0000 / bg2168@cumc.columbia.edu
Additional Study Information: Due to the high volume of inquiries, please inquire through RecruitMe. A study to isolate and determine the antibody response in patients who have recovered from COVID-19 for the development of monoclonal antibodies for prevention and treatment of coronavirus infections. We are doing this study to develop antibodies against coronavirus to prevent and treat diseases like COVID-19. This study will require one study visit for blood draw in order to examine the antibodies created by your cells, using advanced techniques in the laboratory. If you have been diagnosed with COVID-19 and have recovered, you may be eligible for this study. Due to the volume of inquiries, please send an inquiry through RecruitMe by clicking the "Do You Qualify" button.
This study is closed
Investigator
David Ho, MD
Do You Qualify?
Are you between the ages of 18-65? Yes No
Have you tested positive for COVID-19? Yes No
Submit
Cancel
You may be eligible for this study

Place Holder



Cancel
For more information, please contact:
Brett Gray
bg2168@cumc.columbia.edu
000-000-0000
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE